ABSTRACT

Nano-technology refers to an emerging field of science that includes synthesis and development of various nanomaterials. Now a days nano-particles are used to treat various chronic and acute diseases such (diabetes, cancer etc). Nanotechnology in diabetes research has facilitated the development of novel glucose measurement and insulin delivery modalities which hold the potential to dramatically improve quality of life for diabetics. The ideal treatment for DM is to find a less expensive anti-diabetic substitute that can work on numerous disease-related targets and pathways. Exciting new opportunities in biological and medication delivery applications have been made possible by nanotechnology. Zinc oxide nanoparticles (ZnO-NPs), one of the emerging nanoparticle agents, have significant implications for treating numerous diseases, including DM. The inherent drawbacks of conventional cancer treatments served as a catalyst for the development and application of various nanotechnologies for safer and more effective cancer treatment, a field referred to as cancer nanomedicine. Despite tremendous technological progress in this area, the complexity and unpredictability of cancer patients tumour biology continue to be the key obstacles to nanomedicine's establishment of a new paradigm in cancer therapy. Keywords: Nano-technology, Diabetics, Nano-medicine, Cancer, Zinc oxide nanoparticles
Publication date: 01/05/2024

https://ijbpas.com/pdf/2024/May/MS_IJBPAS_2024_7980.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.5.7980